| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.011 | 0.8 |